top of page

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in Nebraska in 2022.

Economic
Output
$7.1B
Direct Jobs Supported by the Industry
4,490
Total Jobs Supported by the Industry
19,358
State Total Vendor Relationships
200
State Total Vendor Spending
$106,156,647
Clinical Trials
1,079
Clinical Trial Participants
1,286,445
bottom of page